# FDA 483 - Suzhou Union Biopharm Co., Ltd. - May 26, 2023

Source: https://www.globalkeysolutions.net/records/483/suzhou-union-biopharm-co-ltd/72b0ef24-b8c6-4983-87f4-e4bae0c3c2fa

> FDA 483 for Suzhou Union Biopharm Co., Ltd. on May 26, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Suzhou Union Biopharm Co., Ltd.
- Inspection Date: 2023-05-26
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2023-05-26](https://www.globalkeysolutions.net/records/483/suzhou-union-biopharm-co-ltd/ef4470dd-f6c7-4bad-9bb8-5e2d34e10adc)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/suzhou-union-biopharm-co-ltd/2b7c64c2-6541-4f6b-aead-45a36d3b7711)

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/yi-zhang/7f5f3567-5f6e-4579-a978-00003fd841d4)
- [Wendy G. Tan](https://www.globalkeysolutions.net/people/wendy-g-tan/aad9c7d5-1a63-43b6-bc25-531b7f4475a9)
- [Lane V. Christensen](https://www.globalkeysolutions.net/people/lane-v-christensen/fb30085e-494e-460e-9f3d-c480902d6468)

Company: https://www.globalkeysolutions.net/companies/suzhou-union-biopharm-co-ltd/5d9c9c07-1afc-44da-b4ff-872317d01143

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd